The challenges of product- and process-related impurities to an evolving biopharmaceutical industry

Bioanalysis. 2013 Jan;5(2):123-6. doi: 10.4155/bio.12.314.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biopharmaceutics / trends*
  • Biotechnology / trends
  • Drug Discovery / trends
  • Drug Industry / trends*
  • Humans